Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Seres Therapeutics (MCRB) Long-Term Debt Issuances (2022 - 2023)

Seres Therapeutics' Long-Term Debt Issuances history spans 2 years, with the latest figure at $103.4 million for Q2 2023.

  • For Q2 2023, Long-Term Debt Issuances changed N/A year-over-year to $103.4 million; the TTM value through Sep 2024 reached $103.4 million, changed 0.0%, while the annual FY2023 figure was $103.4 million, 274.48% up from the prior year.
  • Long-Term Debt Issuances for Q2 2023 was $103.4 million at Seres Therapeutics, up from $27.6 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $103.4 million in Q2 2023 and bottomed at $27.6 million in Q1 2022.